Loading... (0%)
About liver disease

COMPANY LIFE

We are a late-stage biopharmaceutical company dedicated to high unmet medical needs.
Learn more
Find out our about current job opportunities or submit your spontaneous application explaining your project.
LEARN MORE

DOCUMENTATION

Update on Corporate Governance

Joint interview: Jean-François Mouney, Co-founder, Chairman of the Board; Pascal Prigent, new CEO; Dean Hum, Chief Operating Officer & Chief Scientific Officer

 

Read “Update on Corporate Governance”

AASLD 2019 Investor and Analyst KOL Event Webcast Replay

Investor and Analyst KOL Event –  November 11th 2019

Access the replay of the webcast here

Events

View all events
massa Sed eget venenatis, facilisis Aenean ut mi, sem, amet,